Overall | Patient 1 | Patient 2 | Patient 3 | Patient 4 | |
---|---|---|---|---|---|
Age (y)+ | 81 (69–86) | 79 | 69 | 83 | 86 |
Female sex* | 1 (25%) | – | – | Yes | – |
Premorbid mRS (0–5) + | 1.5 (0–3) | 1 | 3 | 2 | 0 |
Stroke characteristics | |||||
Location of large vessel occlusion | n.a | R. ICA/M1 | R. ICA (functional occlusion)/M1 | L. ICA (functional occlusion)/M1/M2 | L. ICA/M1 |
NIHSS (0–42)+ | 17.5 (15–21) | 15 | 19 | 21 | 16 |
ASPECTS (0–10)+ | 7 (6–10) | 6 | 6 | 10 | 8 |
Prior medication* | |||||
Antiplatelet agents | 3 (75%) | ASA + Clopidogrel | ASA | ASA | – |
Statin | 0 (0%) | – | – | – | – |
Comorbidities* | |||||
Arterial hypertension | 4 (100%) | Yes | Yes | Yes | Yes |
Coronary heart disease | 3 (75%) | Yes | Yes | Yes | – |
Atrial fibrillation | 1 (25%) | – | – | Yes | – |
Previous Stroke | 1 (25%) | – | Yes | – | – |
Chronic kidney disease/hemodialysis | 3 (75%)/1 (25%) | Yes/– | Yes/– | Yes/yes | – |
Peripheral arterial occlusive disease | 1 (25%) | Yes | – | – | – |
Known carotid artery stenosis | 3 (75%) | Yes | Yes | Yes | – |
Diabetes mellitus | 1 (25%) | – | Yes | – | – |
Hypercholesterolemia | 2 (50%) | Yes | – | Yes | – |